We are looking for young people 2–17 years old to join a Crohn’s disease (CD) clinical trial to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or moderately to severely active IBD (including associated symptoms such as recurrent diarrhea, growth failure, cramps, chronic fatigue and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the Crohn’s disease studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Act now.
